AngioDynamics, Inc. (NASDAQ:ANGO) reported Q4 2017 earnings this Morning, coming in at $0.19 per share, beating Wall Street’s estimates of $0.16 per Share. Revenue for the quarter came in at $86.90 million missing the streets estimates of $90.72 million
Analyst Coverage For AngioDynamics, Inc. (NASDAQ:ANGO)
These are 2 Hold Ratings, 3 Buy Ratings .
The current consensus rating for AngioDynamics, Inc. (NASDAQ:ANGO) is Buy (Score: 2.60) with a consensus target price of $18.50 , a potential (14.06% upside)Recent Insider Trading for AngioDynamics, Inc. (NASDAQ:ANGO)
- On 4/12/2017 Avista Capital Partners Gp, Ll, Major Shareholder, sold 2,350,000 with an average share price of $16.00 per share and the total transaction amounting to $37,600,000.00.
- On 8/5/2016 Avista Capital Partners Gp, Ll, Major Shareholder, sold 2,241,000 with an average share price of $14.62 per share and the total transaction amounting to $32,763,420.00.
- On 8/5/2016 David F Burgstahler, Director, sold 2,250,000 with an average share price of $14.62 per share and the total transaction amounting to $32,895,000.00.
- On 5/6/2016 Charles R Greiner, VP, sold 3,508 with an average share price of $12.31 per share and the total transaction amounting to $43,183.48.
- On 4/25/2016 Stephen A Trowbridge, SVP, sold 12,940 with an average share price of $12.30 per share and the total transaction amounting to $159,162.00.
- On 4/14/2014 Matthew Kapusta, SVP, bought 1,000 with an average share price of $13.90 per share and the total transaction amounting to $13,900.00.
Recent Trading for AngioDynamics, Inc. (NASDAQ:ANGO) Shares of AngioDynamics, Inc. closed the previous trading session at 15.70 down -0.52 -3.21% with 198,924 shares trading hands.